Company Overview

Update
Headquarters:
Greenwich, NY
Funding:
$8M
Categories:
Biotechnology

Agilis Biotherapeutics is focused on designing and engineering DNA-based therapeutics for life-threatening or fatal rare diseases.

Description

Update

Agilis Biotherapeutics, LLC is a biotechnology company focused on designing and engineering first-in-class DNA-based therapeutics to improve and save the lives of patients affected by life-threatening or fatal rare diseases for which there are no or limited treatment options. We believe that engineered DNA-based therapeutics provide the ability to target underlying disease mechanisms with tightly-controlled multigenic modalities leading to “functional cures” for patients with these diseases.

Current Team (1)

Update

Funding Rounds (1) - $8M

Update
  • $8M

    Investors Unknown
    Jan 1, 2014 -Unknown

Offices/Locations (1)

Update
  • Office

    Greenwich, NY

    USA

Images (1)

Update
  • 38c736359675d89c1398e45dca5c6203